Surgical Resection and Intraoperative Cesium-131 Brachytherapy for Head and Neck Cancer
Status:
Active, not recruiting
Trial end date:
2021-07-01
Target enrollment:
Participant gender:
Summary
This pilot clinical trial studies cesium Cs 131 brachytherapy in treating patients with head
and neck cancer that has come back (recurrent) and can be removed by surgery. Brachytherapy,
also known as internal radiation therapy, uses radioactive material placed directly into or
near a tumor to kill tumor cells. Radioactive drugs, such as cesium Cs 131, may carry
radiation directly to tumor cells and not harm normal cells. Permanently implanting cesium Cs
131 into the wound bed after surgery may help treat microscopic cancer cells that may be in
the tissue after surgical removal of the tumor.
Phase:
Early Phase 1
Details
Lead Sponsor:
Sidney Kimmel Cancer Center at Thomas Jefferson University